BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Novartis
McKesson
Argus Health
US Department of Justice
Covington
Colorcon
Johnson and Johnson
Federal Trade Commission
Chinese Patent Office

Generated: January 16, 2018

DrugPatentWatch Database Preview

Details for Patent: 9,278,182

« Back to Dashboard

Summary for Patent: 9,278,182
Title:Devices, systems and methods for medicament delivery
Abstract: An apparatus includes a label configured to be coupled to a medicament delivery device. The label includes a first surface and a second surface. The first surface is configured to be coupled to an outer surface of the medicament delivery device. The second surface includes a textual indicia. The label further includes an electronic circuit system configured to output an electronic signal.
Inventor(s): Edwards; Eric S. (Moseley, VA), Edwards; Evan T. (Charlottesville, VA), Licata; Mark J. (Doswell, VA), Meyers; Paul F. (Fishers, IN), Weinzierl; David A. (Andover, MN)
Assignee: kaleo, Inc. (Richmond, VA)
Application Number:14/664,426
Patent Claim Types:
see list of patent claims
Delivery; Device;

Drugs Protected by US Patent 9,278,182

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Kaleo Inc AUVI-Q epinephrine INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS 201739-002 Aug 10, 2012 BX RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Kaleo Inc AUVI-Q epinephrine INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS 201739-001 Aug 10, 2012 BX RX Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Kaleo Inc EVZIO naloxone hydrochloride SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 205787-001 Apr 3, 2014 DISCN Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Kaleo Inc EVZIO naloxone hydrochloride SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS 209862-001 Oct 19, 2016 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 9,278,182

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,278,177 Medical injector with compliance tracking and monitoring ➤ Subscribe
7,731,690 Devices, systems and methods for medicament delivery ➤ Subscribe
8,105,281 Devices, systems and methods for medicament delivery ➤ Subscribe
8,361,029 Devices, systems and methods for medicament delivery ➤ Subscribe
7,416,540 Devices systems and methods for medicament delivery ➤ Subscribe
8,608,698 Devices, systems and methods for medicament delivery ➤ Subscribe
8,425,462 Devices, systems, and methods for medicament delivery ➤ Subscribe
7,947,017 Devices, systems and methods for medicament delivery ➤ Subscribe
8,226,610 Medical injector with compliance tracking and monitoring ➤ Subscribe
8,206,360 Devices, systems and methods for medicament delivery ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 9,278,182

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Poland 2285360 ➤ Subscribe
New Zealand 589864 ➤ Subscribe
New Zealand 570731 ➤ Subscribe
New Zealand 560516 ➤ Subscribe
New Zealand 555256 ➤ Subscribe
Mexico 2008012446 ➤ Subscribe
Mexico 2007009152 ➤ Subscribe
Mexico 2007005946 ➤ Subscribe
Mexico 337305 ➤ Subscribe
Mexico 2010012334 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
AstraZeneca
Queensland Health
QuintilesIMS
Fuji
Johnson and Johnson
Harvard Business School
Fish and Richardson
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot